PDLIM4 and Familial prostate cancer: PDZ and LIM domain 4 (PDLIM4), also known as RIL, is thought to be a suppressor of ovarian, breast and prostate cancers, and its low expression has been associated with hypermethylation in both primary BRCA and lymph node metastases (53–55).